GlassScriptPhysician profile
Hunter Glasgow
NPI 1942856232
$1,464.90
in general payments reported to CMS, 2019-2025
22 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $741 · 2024: $336 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,464.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $178.27 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $178.18 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $172.96 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $137.40 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.78 | 2023-2025 | Jardiance, Synjardy |
| Amgen INC. | $84.62 | 2024-2025 | Otezla, Repatha, Krystexxa |
| Glaxosmithkline, LLC. | $83.49 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $76.82 | 2025 | Gemtesa |
| Exact Sciences Corporation | $59.26 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $52.61 | 2023-2025 | Airsupra, Breztri |
| Pfizer INC. | $51.77 | 2023 | |
| Shield Therapeutics INC | $44.49 | 2023 | Accrufer |
| Astellas Pharma US INC | $42.59 | 2023 | Veozah, Myrbetriq |
| E.R. Squibb & Sons, L.L.C. | $37.55 | 2023-2025 | Eliquis |
| Insulet Corporation | $27.32 | 2025 | Omnipod |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $25.65 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $24.64 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $21.17 | 2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $18.31 | 2023 | Verquvo, Belsomra |
| Dynavax Technologies Corporation | $17.66 | 2023 | Heplisav-B |
| Novartis Pharmaceuticals Corporation | $16.83 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Glasgow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.